Experience
Sandoz, Inc. et al v. Pharmacyclics LLC
Sandoz, Inc.
Pharmacyclics LLC; Janssen Biotech, Inc.
Represented patent owner in inter partes review (IPR) challenge related to Imbruvica® (ibrutinib) for the treatment of chronic graft versus host disease.
Sandoz, Inc. v. Pharmacyclics LLC; Janssen Biotech, Inc., IPR2019-00865, PTAB, Judges Cotta, Snedden, Mitchell
